Clinical Trials Directory

Trials / Unknown

UnknownNCT05837000

Dexmedetomidine, Ketamine and Magnesium Sulphate in Caudal Block for Hypospadias Repair

Role of Adding Dexmedetomidine, Ketamine and Magnesium Sulphate to Caudal Block as Preemptive Analgesia in Hypospadias Repair in Pediatrics: a Randomized Double-blinded Trial

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
75 (estimated)
Sponsor
Kafrelsheikh University · Academic / Other
Sex
Male
Age
1 Year – 7 Years
Healthy volunteers
Not accepted

Summary

Caudal epidural block is a rapid, reliable, and safe technique that can be used with general anesthesia for intraoperative and postoperative analgesia in pediatric patients Ketamine is a selective antagonist of N-methyl-D-aspartate (NMDA) receptor, an ionotropic glutamate receptor.

Conditions

Interventions

TypeNameDescription
DRUGDexmedetomidinePatient will receive 0.5 ml/kg bupivacaine 0.25% + 1μg/kg dexmedetomidine caudally
DRUGKetaminePatient will receive 0.5ml/kg bupivacaine 0.25% + 0.5mg/kg ketamine caudally
DRUGMagnesium sulphatePatient will receive 0.5ml/kg bupivacaine 0.25% + 1ml volume containing 50mg of magnesium caudally.

Timeline

Start date
2023-05-15
Primary completion
2024-10-25
Completion
2024-10-25
First posted
2023-05-01
Last updated
2023-06-13

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05837000. Inclusion in this directory is not an endorsement.